13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000905148-25-000652
Total Value
$170.7M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PHARVARIS N V | PHVS | 4,289,304 | $82.2M | 48.17% |
| 2 | ALUMIS INC | ALMS | 2,787,398 | $21.9M | 12.83% |
| 3 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 539,194 | $18.6M | 10.87% |
| 4 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $16.2M | 9.49% |
| 5 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 1,519,971 | $15.3M | 8.98% |
| 6 | ACELYRIN INC | 00445A100 | 3,806,410 | $12.0M | 7.00% |
| 7 | LYELL IMMUNOPHARMA INC | LYEL | 7,102,190 | $4.5M | 2.66% |